BenQ Medical Technology Cash Flow-to-Debt Ratio
BenQ Medical Technology cash flow-to-debt ratio. BenQ Medical Technology (4116) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2026, meaning its operating cash flow of NT$148.51 Million could theoretically repay 0% of its total liabilities (NT$3.24 Billion) in one year. Check BenQ Medical Technology cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BenQ Medical Technology (2017–2025)
Cash flow-to-debt ratio of BenQ Medical Technology from 2017 to 2025. Historical debt coverage capacity for BenQ Medical Technology across 9 annual periods. Check total reinvestment intensity of BenQ Medical Technology to assess the company's total reinvestment commitment from operating cash flow.
BenQ Medical Technology Cash Flow-to-Debt Ratio by Year (2017–2025)
BenQ Medical Technology cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for BenQ Medical Technology. For the full cash flow conversion analysis, see 4116 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | NT$358.75 Million | NT$3.12 Billion | ▲ +53.9% |
| 2024 | 0.07x | NT$222.22 Million | NT$2.97 Billion | ▼ -57.2% |
| 2023 | 0.17x | NT$442.35 Million | NT$2.53 Billion | ▼ -23.4% |
| 2022 | 0.23x | NT$378.77 Million | NT$1.66 Billion | ▲ +60.7% |
| 2021 | 0.14x | NT$121.35 Million | NT$855.51 Million | ▼ -36.5% |
| 2020 | 0.22x | NT$151.48 Million | NT$677.80 Million | ▼ -22.7% |
| 2019 | 0.29x | NT$169.23 Million | NT$585.25 Million | ▲ +35.1% |
| 2018 | 0.21x | NT$126.10 Million | NT$589.30 Million | ▲ +39.5% |
| 2017 | 0.15x | NT$72.97 Million | NT$475.80 Million | — |